Welcome to Caravan Biologix, where innovation meets purpose in the pursuit of revolutionizing therapeutic delivery systems. Our journey began as a mere thought experiment, driven by a passion to address the persistent challenges facing whole cell Chimeric Antigen Receptor (CAR) therapeutics in combatting solid tumor cancers. Further, recognizing the limitations of existing delivery systems such as AAVs, Anelloviruses, exosomes, microsomes, and Liponanoparticles (LNPs), we embarked on a quest to redefine the landscape of drug delivery.

​

The culmination of our endeavors resulted in the birth of the CAR-mediated bionanovesicle, appropriately termed the mini-CAR BioNV. This groundbreaking technology stands poised to disrupt conventional paradigms, offering a promising solution for a myriad of human and animal diseases. From solid tumor cancers to infectious diseases, metabolic disorders to degenerative conditions, and beyond, the potential applications of mini-CAR BioNV are as vast as they are transformative.

​

At Caravan Biologix, our mission is crystal clear - to significantly elevate the efficacy and accessibility of CAR therapeutics as well as biologic and drug delivery systems. We are driven by a steadfast commitment to advancing our novel CAR-Directed BioNanoVesicle platform technology, propelling it into a new echelon of therapeutics capable of addressing a spectrum of human ailments. Behind this mission stands a dedicated team of healthcare professionals, united by a shared vision of pioneering change in the field of biomedicine.

​

Join us on this journey as we embark on a path toward reshaping the future of healthcare. Together, we strive to unlock new possibilities in the treatment of diseases, forging a brighter and healthier tomorrow for all. Caravan Biologix - where innovation meets compassion, and where the journey toward better health begins.